[1] |
Eltchaninoff H, Prat A, Gilard M, et al. Transcatheter aortic valve implantation: early results of the France (French Aortic National CoreValve and Edwards) registry[J]. Eur Heart J, 2011, 32(2): 191-7. doi: 10.1093/eurheartj/ehq261
|
[2] |
Hamm CW, Moellmann H, Holzhey D, et al. The German aortic valve registry(Gary):in-hospital outcome[J]. Eur Heart J, 2014, 35(24): 1588-98. doi: 10.1093/eurheartj/eht381
|
[3] |
Herrmann HC, Thourani VH, Kodali SK, et al. One-Year clinical outcomes with SAPIEN 3 transcatheter aortic valve replacement in high-risk and inoperable patients with severe aortic stenosis[J]. Circulation, 2016, 134(2): 130-40. doi: 10.1161/CIRCULATIONAHA.116.022797
|
[4] |
Liu H, Yang Y, Lu YT, et al. Transapical transcatheter aortic valve replacement for high risk pure non-calcified aortic regurgitation:two years outcome of a multi-center study[J]. Chinese J Surg, 2018, 56(12): 910-5.
|
[5] |
Mack MJ, Leon MB, Smith CR, et al. 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial[J]. Lancet, 2015, 385(9986): 2477-84. doi: 10.1016/S0140-6736(15)60308-7
|
[6] |
Shuto T, Miyamoto S. Transcatheter aortic valve implantation for sever aortic valve stenosis[J]. Kyobu Geka, 2018, 71(10): 815-20.
|
[7] |
Shen Y, Zhang H, Zhang L, et al. Transcatheter aortic valve replacement with balloon-expandable valve Analysis of initial experience in China[J]. Herz, 2018, 43(8): 746-51. doi: 10.1007/s00059-017-4622-x
|
[8] |
Gilard M, Eltchaninoff H, Iung B, et al. Registry of transcatheter aortic-valve implantation in high-risk patients[J]. N Engl J Med, 2012, 366(18): 1705-15. doi: 10.1056/NEJMoa1114705
|
[9] |
李 慧, 王建德, 段福建, 等. 超声心动图在经心尖主动脉瓣人工瓣膜植入术治疗主动脉瓣狭窄患者中的应用价值[J]. 中华医学超声杂志:电子版, 2017, 14(3): 181-5.
|
[10] |
Nagaraja V, Suh W, Fischman DL, et al. Transcatheter aortic valve replacement outcomes in bicuspid compared to trileaflet aortic valves[J]. Cardiovasc Revasculariz Med, 2018, 72(9): 1015-23.
|
[11] |
Komagamine M, Furukawa N, Gummert JA. Posterior papillary muscle rupture after transapical transcatheter aortic valve implantation[J]. Europ J Card Thoracic Surg, 2018, 54(3): 596-7. doi: 10.1093/ejcts/ezy103
|
[12] |
Blackstone EH, Suri RM, Rajeswaran J, et al. Propensity-Matched comparisons of clinical outcomes after transapical or transfemoral transcatheter aortic valve replacement a placement of aortic transcatheter valves (PARTNER)-I trial substudy[J]. Circulation, 2015, 131(22): 1989-93. doi: 10.1161/CIRCULATIONAHA.114.012525
|
[13] |
Furukawa N, Kuss O, Emmel E, et al. Minimally invasive versus transapical versus transfemoral aortic valve implantation: A one-to-one-to-one propensity score-matched analysis[J]. J Thoracic Cardiovasc Surg, 2018, 156(5): 1825-34. doi: 10.1016/j.jtcvs.2018.04.104
|
[14] |
Greenbaum AB, Babaliaros VC, Chen MY, et al. Transcaval access and closure for transcatheter aortic valve replacement a prospective investigation[J]. J Am Coll Cardiol, 2017, 69(5): 511-21. doi: 10.1016/j.jacc.2016.10.024
|
[15] |
Conzelmann LO, Wurth A, Schymik G, et al. Feasibility of transcatheter aortic valve implantation in patients with coronary heights ≤ 7 mm: insights from the transcatheter aortic valve implantation Karlsruhe(TAVIK)registry[J]. Eur J Cardiothorac Surg, 2018, 54(4): 752-61. doi: 10.1093/ejcts/ezy130
|
[16] |
Kumar N, Khera R, Fonarow GC, et al. Comparison of outcomes of transfemoral versus transapical approach for transcatheter aortic valve implantation[J]. Am J Cardiol, 2018, 122(9): 1520-6. doi: 10.1016/j.amjcard.2018.07.025
|
[17] |
Zhu LM, Guo YQ, Wang W, et al. Transapical transcatheter aortic valve replacement with a novel transcatheter aortic valve replacement system in high-risk patients with severe aortic valve diseases[J]. J Thorac Cardiovasc Surg, 2018, 155(2): 588-97. doi: 10.1016/j.jtcvs.2017.09.015
|
[18] |
Kahlert P, Al-Rashid F, Döttger P, et al. Cerebral embolization during transcatheter aortic valve implantation: a transcranial Doppler study[J]. Circulation, 2012, 126(10): 1245-55. doi: 10.1161/CIRCULATIONAHA.112.092544
|
[19] |
Kodali S, Thourani VH, White JA, et al. Early clinical and echocardiographic outcomes after SAPIEN 3 transcatheter aortic valve replacement in inoperable, high-risk and intermediate-risk patients with aortic stenosis[J]. Eur Heart J, 2016, 37(28): 2252-62. doi: 10.1093/eurheartj/ehw112
|
[20] |
Kolte D, Khera S, Sardar MR, et al. Thirty-Day readmissions after transcatheter aortic valve replacement in the United States insights from the nationwide readmissions database[J]. Circ Cardiovasc Interv, 2017, 10(1): 98-107.
|
[21] |
Arora S, Strassle PD, Kolte D, et al. Length of stay and discharge disposition after transcatheter versus surgical aortic valve replacement in the United States[J]. Circ Cardiovasc Interv, 2018, 11(9): 1207-19.
|